West Nile Virus infection with hearing loss

Journal of Infection

Volumn 53, Issue 5, 2006, Pages

  McBride, Wes ^a   Gill, Kanwar R S ^a   Wiviott, Lory ^a  

^a CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

Author keywords

Encephalitis; Hearing loss; Immunosuppression; Myasthenia gravis; West Nile Virus

Indexed keywords

AZATHIOPRINE; CIPROFLOXACIN; COTRIMOXAZOLE; PIPERACILLIN PLUS TAZOBACTAM; PREDNISONE; VANCOMYCIN;

ADULT; ARTICLE; AUDIOGRAPHY; CASE REPORT; CEREBROSPINAL FLUID ANALYSIS; DRUG HYPERSENSITIVITY; DRUG WITHDRAWAL; FEMALE; FEVER; FLACCID PARALYSIS; HEADACHE; HEARING LOSS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LEUKOPENIA; LUMBAR PUNCTURE; MENINGOENCEPHALITIS; MYASTHENIA GRAVIS; NAUSEA; PHOTOPHOBIA; PYELONEPHRITIS; THYMOMA; THYMUS SURGERY; TREMOR; URINALYSIS; URTICARIA; VISUAL FIELD DEFECT; VOMITING; WEST NILE FLAVIVIRUS;

DISEASE TRANSMISSION, HORIZONTAL; FEMALE; HEARING LOSS; HUMANS; IMMUNOCOMPROMISED HOST; IMMUNOSUPPRESSIVE AGENTS; MIDDLE AGED; MYASTHENIA GRAVIS; WEST NILE FEVER;

EID: 33749520440     PISSN: 01634453     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jinf.2006.01.017     Document Type: Article

References (16)

1. Hayes E.B. Epidemiology and transmission dynamics of West Nile virus disease. JAMA 290 (2003) 1318
2. Sejvar J.J., Haddad M.B., Tierney B.C., Campbell G.L., Marfin A.A., Van Gerpen J.A., et al. Neurologic manifestations and outcome of West Nile virus infection. Muscle Nerve 28 (2003) 302-308
3. Leis A.A., Stokic D.S., Webb R.M., Slavinski S.A., and Fratkin J. Clinical spectrum of muscle weakness in human West Nile virus infection. Emerg Infect Dis 9 (2003) 788-793
4. Sejvar J.J., Leis A.A., Stokic D.S., Van Gerpen J.A., Marfin A.A., Webb R., et al. Acute flaccid paralysis and West Nile virus infection. Curr Treat Options Neurol 7 (2005) 15-22
5. Leis A.A., and Stokic D.S. Neuromuscular manifestations of human West Nile Virus infection. J Heart Lung Transplant 24 (2005) 621-623
6. Bragin-Sanchez D., and Chang P.P. West Nile virus encephalitis infection in a heart transplant recipient: a case report. J Heart Lung Transplant 24 (2005) 621-623
7. Wadei H., Alangaden G.J., Sillix D.H., El-Amm J.M., Gruber S.A., West M.S., et al. West Nile virus encephalitis: an emerging disease in renal transplant recipients. Clin Transplant 18 (2004) 753-758
8. Ravindra K.V., Freifeld A.G., Kalil A.C., Mercer D.F., Grant W.J., Botha J.F., et al. West Nile virus-associated encephalitis in recipients of renal and pancreas transplants: case series and literature review. Clin Infect Dis 39 (2004) 1398-1399
9. Hong D.S., Jacobson K.L., Raad I.I., de Lima M., Anderlini P., Fuller G.N., et al. West Nile encephalitis in 2 hematopoietic stem cell transplant recipients: case series and literature review. Clin Infect Dis 37 (2003) 1044-1049
10. Centers for Disease Control and Prevention (CDC). MMWR Morb Mortal Wkly Rep 54 (2005) 964-965 [Update: West Nile virus activity-United States, 2005]
11. Casella E.B., Cypel S., Osmo A.A., Okay Y., Lefevre B.H., Lichtig I., et al. Sequelae from meningococcal meningitis in children: a critical analysis of dexamethasone therapy. Arq Neuropsiquiatr 62 (2004) 421-428 [Epub 2004 Jul 20]
12. Bao X., and Wong V. Brainstem auditory-evoked potential evaluation in children with meningitis. Pediatr Neurol 19 (1998) 109-112
13. Traber P.G., and Levine D.P. Vancomycin ototoxicity in patient with normal renal function. Ann Intern Med 95 (1981) 458-460
14. Mellor J.A., Kingson J., Carrferkey M., and Keane C. Vancomycin ototoxicity in patients with normal renal function. Br J Audiol 18 (1984) 179-796
15. Brummett R.E., and Fox K.E. Vancomycin- and erythromycin-induced hearing loss in humans. Antimicrob Agents Chemother 33 (1989) 791-796
16. Gea-Banacloche J., Johnson R.T., Bagic A., Butman J.A., Murray P.R., and Agrawal A.G. West Nile virus: pathogenesis and therapeutic options. Ann Intern Med 140 (2004) 545-553